• AI-10-49: An Assay-First AML Strategy

  2026-09-04

  AI-10-49 is a selective CBFβ-SMMHC inhibitor for dissecting fusion-driven acute myeloid leukemia. This assay-first guide connects target engagement, RUNX1 chromatin restoration, and the N-MYC/eIF4G1 survival program to practical experimental decisions.

• Gramine–MTDH Ferroptosis in Triple-Negative Breast Cancer

  2026-09-04

  This study identifies gramine as a potential inhibitor of triple-negative breast cancer and defines a CUL3–MTDH regulatory mechanism that promotes ferroptosis. Its combination of chemical screening, target-validation assays, ferroptosis rescue experiments, and tumor models provides a useful framework for studying ubiquitin-regulated cell death in TNBC.

• Cy5 Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-03

  The Cy5 Goat Anti-Mouse IgG (H+L) Antibody is a Cy5-conjugated secondary antibody for sensitive mouse IgG detection in IHC, ICC, and flow cytometry. Its affinity-purified polyclonal design supports signal amplification, while defined buffer and storage conditions guide reproducible handling.

• Beyond Viability: Interpreting Cancer Drug Responses

  2026-09-03

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework that separates growth inhibition from cell killing, helping researchers design more informative response assays and interpret drug effects across time.

• Brain-to-Spinal Circuits Control Mechanical Allodynia

  2026-09-02

  This Cell Reports study identifies a contralateral lPBN–hypothalamus–spinal pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Its combination of circuit mapping, cell-type-specific perturbation, behavioral models, and κ-opioid receptor manipulation provides a framework for studying descending pain control and opioid receptor signaling research.

• Epinephrine Bitartrate: Adrenergic Research Guide

  2026-09-02

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist for controlled studies of α- and β-receptor signaling. This guide separates product-dossier specifications from peer-reviewed receptor-binding evidence and provides practical assay boundaries.

• Foretinib: Separating Growth Arrest from Cell Death

  2026-09-01

  Foretinib (GSK1363089) is a multikinase research tool for studying Met- and VEGFR-dependent cancer biology. This guide moves beyond endpoint-only workflows by showing how to distinguish tumor cell growth inhibition, cell death, and motility effects in a time-resolved experimental design.

• Procainamide Hydrochloride in Multimodal Assays

  2026-09-01

  Procainamide Hydrochloride is more than a cardiac sodium channel blocker: it can support mechanism-separated studies spanning Nav1.5 electrophysiology, epigenetic regulation, and immune-cell phenotyping. This article presents an assay framework that connects these domains without conflating their evidence levels.

• Phosbind Acrylamide for Phosphorylation Analysis

  2026-08-31

  Phosbind Acrylamide enables antibody-free, phosphate-dependent mobility analysis in SDS-PAGE, making it useful for kinase assays, signaling time courses, and circadian-clock studies. This guide translates the ISX-9–CaMKIIδ–BMAL1 findings into practical gel controls, workflow decisions, and troubleshooting steps.

• EZ Cap Cy5 Firefly Luciferase mRNA Workflow

  2026-08-31

  Track both where an mRNA goes and whether it produces protein with one dual-reporter transcript. This practical guide connects Cy5 imaging, luciferase quantification, and delivery optimization for nanoparticle, cellular, and translational workflows.

• Fusobacterium EVs and Colorectal Cancer Colonization

  2026-08-30

  Zheng et al. show that extracellular vesicles from Fusobacterium nucleatum accumulate in colorectal cancer and help prepare tumor cells for bacterial adhesion by transferring the adhesin FomA to their surfaces. The work links bacterial vesicle biology with tumor colonization and provides a framework for testing how vesicle uptake, membrane fusion, and adhesion contribute to microbiome-associated cancer progression.

• Heparin Sodium: Mechanism and Research Workflow

  2026-08-29

  Heparin sodium is a glycosaminoglycan anticoagulant that enhances antithrombin-mediated inhibition of factor Xa and thrombin. This article connects its assay and handling properties with thrombosis research while distinguishing established anticoagulation evidence from exploratory nanovesicle biology.

• ARCA Cy5 EGFP mRNA (5-moUTP) Assay Guide

  2026-08-28

  A scenario-based guide to separating mRNA uptake, intracellular localization, translation, and assay toxicity in mammalian-cell experiments. Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, supports direct fluorescence-based analysis and more controlled workflow decisions.

• Atorvastatin, Ferroptosis, and HCC Prognosis

  2026-08-28

  The reference study combines a ferroptosis-related prognostic signature with Connectivity Map screening to identify Atorvastatin as a candidate agent for hepatocellular carcinoma. Its cell and animal experiments support an association between Atorvastatin exposure, ferroptosis induction, and reduced HCC growth and migration, while remaining preclinical and model-dependent.

• NPC1/USP7/p53 Axis in HCC Cholesterol Control

  2026-08-27

  A 2026 Oncogene study identifies NPC1 as an oncogenic coordinator of cholesterol metabolism and p53 destabilization in hepatocellular carcinoma. Its perturbation and rescue experiments connect NPC1, USP7, p53, and SREBP2 to tumor-cell proliferation, while suggesting how replication-focused assays can complement mechanistic studies.

7772 records 1/519 page Next 12345 下5页 Last page